O Nakashima
- Hepatology top 2%
- Epidemiology top 10%
- Surgery
- Oncology
- Molecular Biology
- Co-authors
- Masamichi KojiroM KojiroYutaka NakashimaJun WatanabeChu Chieh HsiaEdward TaborM. KageY. Wada
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (16 papers)Cancer, Lipids, and Metabolism (5 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
O Nakashima
28 papers receiving 764 citations
Peers
Comparison fields: 5 of 60
- Hepatology 498
- Epidemiology 286
- Surgery 221
- Oncology 163
- Molecular Biology 128
Countries citing papers authored by O Nakashima
This map shows the geographic impact of O Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Nakashima more than expected).
Fields of papers citing papers by O Nakashima
This network shows the impact of papers produced by O Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Nakashima. The network helps show where O Nakashima may publish in the future.
Co-authorship network of co-authors of O Nakashima
This figure shows the co-authorship network connecting the top 25 collaborators of O Nakashima. A scholar is included among the top collaborators of O Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Nakashima. O Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 59 | |
| 4 | 111 | |
| 5 | 1 | |
| 6 | 25 | |
| 7 | 21 | |
| 8 | 108 | |
| 9 | Cell cycle inhibitors (p27 Kip1 and p21 CIP1 ) cause hypertrophy in LLC-PK 1 cells | 2 |
| 10 | 38 | |
| 11 | 6 | |
| 12 | 31 | |
| 13 | 25 | |
| 14 | 49 | |
| 15 | [Pathomorphologic characteristics and differential diagnosis of small hepatocellular carcinoma]. | 2 |
| 16 | 5 | |
| 17 | 94 | |
| 18 | 23 | |
| 19 | 3 | |
| 20 | [Familial cerebral aneurysms in three families, with two sibling pairs]. | 1 |
About O Nakashima
O Nakashima is a scholar working on Hepatology, Cancer Research and Oncology, having authored 30 papers that have together received 792 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cancer, Lipids, and Metabolism (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). The work is most often cited by research in Hepatology (498 citations), Epidemiology (286 citations) and Cancer Research (111 citations). O Nakashima has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Masamichi Kojiro, M Kojiro, Yutaka Nakashima, Jun Watanabe, Chu Chieh Hsia, Edward Tabor, M. Kage, Y. Wada, Masaya Tanaka and Fumiaki Marumo. Their work appears in journals such as Journal of Clinical Oncology, Hepatology and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.